Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood‐donor screening

Abstract

These studies demonstrate that HCV 3.0 EIA compared to HCV 2.0 EIA can better detect 1) remote nonviremic HCV infections, 2) acute infection, and 3) HCV antibodies in cases of atypical seroconversion.